{"id":"W3170040752","doi":"10.1093/ecco-jcc/jjab075.025","title":"OP26 Risankizumab induces early clinical remission and response in patients with Moderate-to-Severe Crohn’s Disease: Results from the phase 3 ADVANCE and MOTIVATE studies","year":2021,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Crohn's disease; Internal medicine; Placebo; Population; Gastroenterology; Clinical trial; Randomized controlled trial; Severity of illness; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003734717,0.0006828689,0.002106248,0.0002875468,0.0002850346,0.0007484469,0.0005627507,0.0008507582,0.001840758],"category_scores_gemma":[0.00153625,0.0003532119,0.00170803,0.0002994276,0.000735556,0.0005742457,0.0004075216,0.001567734,0.0003424728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004271523,"about_ca_system_score_gemma":0.0009736991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005211306,"about_ca_topic_score_gemma":0.00196445,"domain_scores_codex":[0.9989415,0.0006733151,0.00007669396,0.0000942805,0.00009931204,0.0001148949],"domain_scores_gemma":[0.9985309,0.0003927035,0.0004148686,0.0001302384,0.000131701,0.0003997392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8924904,0.02050579,0.01007471,0.001339218,0.002189605,0.0001049456,0.0001656203,0.0004921315,0.01593421,0.0001496658,0.001991192,0.0545625],"study_design_scores_gemma":[0.5346891,0.4035693,0.05266553,0.0001013881,0.00178731,0.0002359089,0.00008200727,0.0004632443,0.002744705,0.0001606338,0.003455728,0.00004503667],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904391,0.006409087,0.0002494072,0.0003320905,0.00006496014,0.0007560948,0.0006587974,0.00004745543,0.001042979],"genre_scores_gemma":[0.994181,0.002072749,0.0007973515,0.0004970795,0.000201727,0.0005213479,0.001098089,0.00001238288,0.0006182819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003734717,"threshold_uncertainty_score":0.01975131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01585496638032016,"score_gpt":0.3027418283264162,"score_spread":0.286886861946096,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}